FundedIQ
Biotechnology

Neural Therapeutics: Funding, Investors & Team (Oct 2026)

Neural Therapeutics is a company that focuses on discovering drugs derived from plants and specializes in developing medical treatments and supplements using psychedelic substances.

www.neuraltherapeutics.ca LinkedIn Toronto, Canada 1-10 employees
Total raised
$360k
Rounds
1
Latest
Undisclosed round
May 2024

Neural Therapeutics has raised $360k across 1 funding round on record, the most recent an undisclosed round of $360k announced in May 2024.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Neural Therapeutics Company Profile and Key Stats

Total funding raised
$360k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$360k in May 2024
Employees
1-10
reported band
Headquarters
Toronto, Canada

Latest funding round on record: May 2024.

Neural Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
$360k

Neural Therapeutics Founders and Leadership Team

Name
Role
Contact
Ian Campbell
Founder
—

No contact details are on record for this team yet.

Neural Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
3,107
$2.2M

Neural Therapeutics' latest round of $360k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Neural Therapeutics in Biotechnology and Toronto

Companies Similar to Neural Therapeutics

Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.

Seed $420k

Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…

Undisclosed round $4.4M

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…

Undisclosed round $50.0M

Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…

Undisclosed round $260k

Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…

Undisclosed round $430k

Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…

Undisclosed round $2.5M

ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…

Undisclosed round $360k

Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…

Undisclosed round $3.1M

Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…

Undisclosed round $15.9M

ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…

Undisclosed round $1.8M

Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…

Undisclosed round $720k

NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…

Undisclosed round $60.0M

Neural Therapeutics Funding FAQs

What does Neural Therapeutics do?

Neural Therapeutics is a company that focuses on discovering drugs derived from plants and specializes in developing medical treatments and supplements using psychedelic substances.

How much funding has Neural Therapeutics raised?

Neural Therapeutics has raised $360k across 1 round on record. The most recent is an undisclosed round of $360k announced in May 2024.

When did Neural Therapeutics last raise funding?

Neural Therapeutics' most recent funding round on record is an undisclosed round of $360k, announced in May 2024.

Who founded Neural Therapeutics?

FundedIQ lists Ian Campbell (Founder) at Neural Therapeutics.

Where is Neural Therapeutics headquartered?

Neural Therapeutics is based in Toronto, Ontario, Canada.

How many employees does Neural Therapeutics have?

Neural Therapeutics is in the 1-10 employee band.

How does Neural Therapeutics' funding compare to other Biotechnology startups?

Neural Therapeutics' latest round of $360k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Neural Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neural Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.